Nektar Therapeutics (NKTR) Other Working Capital Changes (2010 - 2026)

Nektar Therapeutics' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$949000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 115.93% year-over-year to -$949000.0; the TTM figure through Mar 2026 stood at $8.5 million (down 6.84% YoY), while the FY2025 annual figure was $15.4 million, up 268.98% from the prior year.
• Other Working Capital Changes was -$949000.0 for Q1 2026 at Nektar Therapeutics, down from $9.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $9.9 million in Q4 2025 to a low of -$5.6 million in Q1 2023.
• Historically, Other Working Capital Changes has averaged $482235.3 across 5 years, with a median of $618000.0 in 2025.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 160.15% in 2022, then soared 510.45% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$2.0 million in 2022, then surged by 142.4% to $867000.0 in 2023, then surged by 179.82% to $2.4 million in 2024, then soared by 306.35% to $9.9 million in 2025, then tumbled by 109.63% to -$949000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$949000.0 (Q1 2026), $9.9 million (Q4 2025), and $618000.0 (Q3 2025), per Business Quant data.